Report Detail

Medical Devices & Consumables Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4659456
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 91 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Extracorporeal membrane oxygenation (ECMO) is an advanced life support technology used to support patients with severe respiratory or circulatory failure. ECMO provides oxygenation and removes carbon dioxide through an extracorporeal circulation system, thereby replacing or assisting the patient's cardiopulmonary function.
This report is a detailed and comprehensive analysis for global Extracorporeal Membrane Oxygenation Therapy (ECMO) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Extracorporeal Membrane Oxygenation Therapy (ECMO) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Extracorporeal Membrane Oxygenation Therapy (ECMO)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Extracorporeal Membrane Oxygenation Therapy (ECMO) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GETINGE, Terumo, NIPRO, Medtronic, LivaNova, XENIOS AG, ALung Technologies, EUROSETS, OriGen Biomedical, MicroPort Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Extracorporeal Membrane Oxygenation Therapy (ECMO) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Veinous (VA)
Venous (VV)
Arteriovenous (AV)
Market segment by Application
Hospital
Clinic
Other
Major players covered
GETINGE
Terumo
NIPRO
Medtronic
LivaNova
XENIOS AG
ALung Technologies
EUROSETS
OriGen Biomedical
MicroPort Scientific
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Extracorporeal Membrane Oxygenation Therapy (ECMO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Extracorporeal Membrane Oxygenation Therapy (ECMO), with price, sales quantity, revenue, and global market share of Extracorporeal Membrane Oxygenation Therapy (ECMO) from 2020 to 2025.
Chapter 3, the Extracorporeal Membrane Oxygenation Therapy (ECMO) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Extracorporeal Membrane Oxygenation Therapy (ECMO) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Extracorporeal Membrane Oxygenation Therapy (ECMO) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Extracorporeal Membrane Oxygenation Therapy (ECMO).
Chapter 14 and 15, to describe Extracorporeal Membrane Oxygenation Therapy (ECMO) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Veinous (VA)
    • 1.3.3 Venous (VV)
    • 1.3.4 Arteriovenous (AV)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size & Forecast
    • 1.5.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity (2020-2031)
    • 1.5.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GETINGE
    • 2.1.1 GETINGE Details
    • 2.1.2 GETINGE Major Business
    • 2.1.3 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.1.4 GETINGE Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GETINGE Recent Developments/Updates
  • 2.2 Terumo
    • 2.2.1 Terumo Details
    • 2.2.2 Terumo Major Business
    • 2.2.3 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.2.4 Terumo Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Terumo Recent Developments/Updates
  • 2.3 NIPRO
    • 2.3.1 NIPRO Details
    • 2.3.2 NIPRO Major Business
    • 2.3.3 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.3.4 NIPRO Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 NIPRO Recent Developments/Updates
  • 2.4 Medtronic
    • 2.4.1 Medtronic Details
    • 2.4.2 Medtronic Major Business
    • 2.4.3 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.4.4 Medtronic Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Medtronic Recent Developments/Updates
  • 2.5 LivaNova
    • 2.5.1 LivaNova Details
    • 2.5.2 LivaNova Major Business
    • 2.5.3 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.5.4 LivaNova Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 LivaNova Recent Developments/Updates
  • 2.6 XENIOS AG
    • 2.6.1 XENIOS AG Details
    • 2.6.2 XENIOS AG Major Business
    • 2.6.3 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.6.4 XENIOS AG Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 XENIOS AG Recent Developments/Updates
  • 2.7 ALung Technologies
    • 2.7.1 ALung Technologies Details
    • 2.7.2 ALung Technologies Major Business
    • 2.7.3 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.7.4 ALung Technologies Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 ALung Technologies Recent Developments/Updates
  • 2.8 EUROSETS
    • 2.8.1 EUROSETS Details
    • 2.8.2 EUROSETS Major Business
    • 2.8.3 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.8.4 EUROSETS Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 EUROSETS Recent Developments/Updates
  • 2.9 OriGen Biomedical
    • 2.9.1 OriGen Biomedical Details
    • 2.9.2 OriGen Biomedical Major Business
    • 2.9.3 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.9.4 OriGen Biomedical Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 OriGen Biomedical Recent Developments/Updates
  • 2.10 MicroPort Scientific
    • 2.10.1 MicroPort Scientific Details
    • 2.10.2 MicroPort Scientific Major Business
    • 2.10.3 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Product and Services
    • 2.10.4 MicroPort Scientific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 MicroPort Scientific Recent Developments/Updates

3 Competitive Environment: Extracorporeal Membrane Oxygenation Therapy (ECMO) by Manufacturer

  • 3.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Extracorporeal Membrane Oxygenation Therapy (ECMO) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Extracorporeal Membrane Oxygenation Therapy (ECMO) Manufacturer Market Share in 2024
  • 3.5 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Overall Company Footprint Analysis
    • 3.5.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Region Footprint
    • 3.5.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Company Product Type Footprint
    • 3.5.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region
    • 4.1.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price by Region (2020-2031)
  • 4.2 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value (2020-2031)
  • 4.3 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value (2020-2031)
  • 4.5 South America Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Type (2020-2031)
  • 5.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Type (2020-2031)
  • 5.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Application (2020-2031)
  • 6.2 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Application (2020-2031)
  • 6.3 Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Type (2020-2031)
  • 7.2 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Application (2020-2031)
  • 7.3 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country
    • 7.3.1 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country
    • 8.3.1 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Region
    • 9.3.1 Asia-Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Type (2020-2031)
  • 10.2 South America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Application (2020-2031)
  • 10.3 South America Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country
    • 10.3.1 South America Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Size by Country
    • 11.3.1 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Extracorporeal Membrane Oxygenation Therapy (ECMO) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Drivers
  • 12.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Market Restraints
  • 12.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Extracorporeal Membrane Oxygenation Therapy (ECMO) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Extracorporeal Membrane Oxygenation Therapy (ECMO)
  • 13.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Extracorporeal Membrane Oxygenation Therapy (ECMO) Typical Distributors
  • 14.3 Extracorporeal Membrane Oxygenation Therapy (ECMO) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Extracorporeal Membrane Oxygenation Therapy (ECMO). Industry analysis & Market Report on Extracorporeal Membrane Oxygenation Therapy (ECMO) is a syndicated market report, published as Global Extracorporeal Membrane Oxygenation Therapy (ECMO) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Extracorporeal Membrane Oxygenation Therapy (ECMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report